Literature DB >> 16635094

Elevated serum surfactant protein A and D in pulmonary alveolar microlithiasis.

Hiroki Takahashi1, Hirofumi Chiba, Masanori Shiratori, Teruo Tachibana, Shosaku Abe.   

Abstract

Pulmonary alveolar microlithiasis (PAM) is a rare disease characterized by widespread localization of calcispherites in the alveolar spaces. The authors report two cases of PAM, with markedly elevated sera concentrations of surfactant protein-A and surfactant protein-D, which showed a tendency to increase as the disease progressed. Therefore, surfactant protein-A and surfactant protein-D may function as serum markers to monitor the disease activity and progression of PAM.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16635094     DOI: 10.1111/j.1440-1843.2006.00844.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  13 in total

Review 1.  Pulmonary alveolar microlithiasis: report of two brothers with the same illness and review of literature.

Authors:  Hussain Al-Sardar; Dhaher J S Al-Habbo; Rami M A Al-Hayali
Journal:  BMJ Case Rep       Date:  2014-03-31

Review 2.  Pulmonary alveolar microlithiasis: an interesting case report with systematic review of Indian literature.

Authors:  Nidhya Ganesan; Marie Moses Ambroise; Anita Ramdas; King Herald Kisku; Kulwant Singh; Renu G' Boy Varghese
Journal:  Front Med       Date:  2015-05-30       Impact factor: 4.592

3.  Immunohistochemical distribution of SP-D, compared with that of SP-A and KL-6, in interstitial pneumonias.

Authors:  Yuji Ohtsuki; Norihiko Nakanishi; Jiro Fujita; Takeo Yoshinouchi; Makoto Kobayashi; Nobuo Ueda; Gang-Hong Lee; Mutsuo Furihata
Journal:  Med Mol Morphol       Date:  2007-09-18       Impact factor: 2.309

4.  Pulmonary alveolar microlithiasis: a case report with emphasis on imaging findings.

Authors:  Guilherme Abdalla; Edson Marchiori; Gláucia Zanetti; Antonio Mucillo; Mariana Leite Pereira; Nina Ventura; Pedro Martins; Carolina Pesce Lamas Constantino; Rodrigo Canellas; Viviane Brandão; Romulo Varella de Oliveira
Journal:  Case Rep Med       Date:  2010-07-04

5.  Modeling pulmonary alveolar microlithiasis by epithelial deletion of the Npt2b sodium phosphate cotransporter reveals putative biomarkers and strategies for treatment.

Authors:  Atsushi Saito; Nikolaos M Nikolaidis; Hassane Amlal; Yasuaki Uehara; Jason C Gardner; Kathleen LaSance; Lori B Pitstick; James P Bridges; Kathryn A Wikenheiser-Brokamp; Dennis W McGraw; Jason C Woods; Yves Sabbagh; Susan C Schiavi; Göksel Altinişik; Marko Jakopović; Yoshikazu Inoue; Francis X McCormack
Journal:  Sci Transl Med       Date:  2015-11-11       Impact factor: 17.956

Review 6.  Pulmonary Alveolar Microlithiasis.

Authors:  Atsushi Saito; Francis X McCormack
Journal:  Clin Chest Med       Date:  2016-06-24       Impact factor: 2.878

7.  Pulmonary alveolar microlithiasis.

Authors:  Surender Kashyap; Prasanta R Mohapatra
Journal:  Lung India       Date:  2013-04

8.  Pulmonary alveolar microlithiasis: A case report and review of the literature.

Authors:  Xu-Dong Zhang; Jin-Ming Gao; Jin-Mei Luo; Yu Zhao
Journal:  Exp Ther Med       Date:  2017-11-07       Impact factor: 2.447

9.  Pulmonary microlithiasis - A case report.

Authors:  Khalid Mahmood; Muhammad Ubaid; Aamer Mahmood
Journal:  Respir Med Case Rep       Date:  2016-08-31

10.  The sodium-phosphate co-transporter SLC34A2, and pulmonary alveolar microlithiasis: Presentation of an inbred family and a novel truncating mutation in exon 3.

Authors:  Marco Favio Michele Vismara; Emma Colao; Fernanda Fabiani; Francesco Bombardiere; Oscar Tamburrini; Caterina Alessio; Francesco Manti; Gerolamo Pelaia; Pasquale Romeo; Rodolfo Iuliano; Nicola Perrotti
Journal:  Respir Med Case Rep       Date:  2015-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.